Clinical trial
Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)
NCT02932722 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2017
- Completion date
- February 7, 2018
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.